Published in Drug Week, July 28th, 2006
Codexis received the award for its technology, Directed Evolution of Three Biocatalysts to Produce the Key Chiral Building Block for Atorvastatin, the Active Ingredient in Lipitor. Lipitor is the world's best-selling drug that lowers cholesterol.
Competing against nominations from both large and small companies, Codexis won in the focus category, 'Greener Reaction Conditions.' The award was presented at the National Academy of Sciences by Susan B. Hazen, acting...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.